Search results
Author(s):
Federico Lombardi
Added:
3 years ago
Atrial fibrillation (AF) is the most common clinical arrhythmia with a relevant socio-economic impact.1–3 Patients with atrial fibrillation are characterised by symptoms such as palpitations and shortness of breath; they have reduced exercise capacity and are subject to a higher risk of thromboembolic events. In spite of a relatively simple diagnosis, management of AF patients is difficult for…
View more
Faizel Osman
Research Area(s) / Expertise: Author
Electrophysiology & Arrhythmia
Job title: University Hospital Coventry, UK
Author(s):
Eyal Nof
,
William G Stevenson
,
Roy John
Added:
3 years ago
Sustained ventricular tachycardia (VT) and ventricular fibrillation (VF) are typically a manifestation of significant structural heart disease and often associated with a high risk of sudden cardiac death. Implantable cardioverter defibrillators (ICDs) remain the mainstay of therapy for prevention of sudden cardiac death associated with these arrhythmias.1 However, ICDs treat the arrhythmia after…
View more
Johannes Brachmann
Job title: Director
Author
Jan Steffel
Job title: Senior Consultant in Electrophysiology and Devices
Author
RIO 2022 – Full Programme: On-Demand
Video Series
Author(s):
Theodoros A Zografos
Added:
3 years ago
Dear Sir,
I read with great interest the elegant review by Mukherjee and colleagues on prophylactic VT ablation in the latest issue of the journal (AER 6(3)125-8).1 The concept is indeed revolutionary, and should extend the boundaries of interventional electrophysiology. However, such an approach cannot be feasible without rationalising patient selection. Current guidelines’ recommendations,…
View more
Fadi Jouhra
Research Area(s) / Expertise:
Author
Author(s):
Michael R Gold
Added:
3 years ago
Dr Michael R Gold (Medical University of South Carolina, Charleston, SC, US) discusses the primary results of the UNTOUCHED trial. The UNTOUCHED trial assesed the 18-month incidence of inappropriate shocks in subjects implanted with the EMBLEM Subcutaneous Implantable Defibrillator (S-ICD) for primary prevention of sudden cardiac death.
Questions:
1. What was the rationale behind the UNTOUCHED…
View more
What Would He Do Next?
Author(s):
Alfred Buxton
Added:
3 years ago
Article